Eco R1 Capital, LLC Gossamer Bio, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $7.17 Million - $16.7 Million	9,195,404 New	9,195,404 $7.63 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $30 Million - $61.9 Million	4,160,887 New	4,160,887 $49.8 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $2.54 Million - $3.22 Million	-294,221 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $3.97 Million - $6.49 Million	-477,875 Reduced 61.89%	294,221 $2.85 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $13.6 Million - $18.5 Million	772,096 New	772,096 $16.7 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.